Platelet inhibitors influence cardioprotection: importance in preclinical study design: reply.
Department of Medicine, Hatter Institute for Cardiovascular Research in Africa and MRC Inter-University Cape Heart Group, University of Cape Town, Cape Town, South Africa.
Sandrine
S
Lecour
Institute of Physiology, Justus-Liebig University, Giessen, Germany.
Rainer
R
Schulz
Clinical Pharmacology, Department of Pharmacology and Pharmacotherapy, Semmelwies University, Budapest, Hungary Pharmahungary Group, Szeged, Hungary.
Péter
P
Ferdinandy
The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, UK The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore d.hausenloy@ucl.ac.uk.
Derek J
DJ
Hausenloy
D000818:Animals; D005069:Evaluation Studies as Topic; D017202:Myocardial Ischemia / Q000628:therapy*; D057170:Translational Research, Biomedical